The Therapeutics Development Network's (TDN) Protocol Review Process ensures optimum safety and quality in cystic fibrosis clinical trial protocols.
Site Search
These award opportunities are designed to support clinical fellows pursuing training in cystic fibrosis-relevant subspecialties.
The Clinical Research Executive Committee (CREC) assesses how a specific protocol fits within the overall clinical research priorities of the cystic fibrosis community and assigns it a rating.
This award provides the opportunity for clinically trained physicians to develop into independent biomedical research investigators who are actively involved in cystic fibrosis-related areas.
The intent of the planning grant is to support the planning of a large, multi-center, investigator-initiated clinical research study that addresses a therapy initiation and modification on ETI (TIME) area of interest.
This award will provide up to six years of support for outstanding, newly trained pediatricians and internists (MDs and MD/PhDs) to complete sub-specialty training, develop into independent investigators, and initiate a research program.
Multiple Principal Investigator Clinical Awards are offered to provide support for multi-investigator-initiated clinical research projects that have the potential to make an important contribution to the Cystic Fibrosis Foundation’s mission.
Committed to maintaining a strong cystic fibrosis provider workforce, the Cystic Fibrosis Foundation will recruit a cohort of advanced practice providers to the new LEAPP CF Fellowship program to expand the number of CF providers in outpatient pediatric and adult care programs.
The Postdoc-to-Faculty transition award is designed to support postdoctoral research fellows during their cystic fibrosis fellowship and aid in their transition to an independent research faculty position.